Coumarin-Ser-Asp-Lys-Pro-OH, a fluorescent substrate for determination of angiotensin-converting enzyme activity via high-performance liquid chromatography.

N-Acetyl-Ser-Asp-Lys-Pro-OH (AcSDKP-OH), a negative regulator of hematopoietic stem cell proliferation, is shown to be a physiological substrate of angiotensin I-converting enzyme (ACE), a zinc-dipeptidyl carboxypeptidase, involved in cardiovascular homeostasis. Recently, a study carried out on captopril-treated volunteers revealed that the kinetics of [3H]AcSDKP-OH hydrolysis in vitro in the plasma of donors correlates closely to the plasmatic ratio angiotensin II/angiotensin I, which characterized the conversion activity of ACE. This prompted us to design a fluorescent substrate, 2-[7-(dimethylamino)-2-oxo-2H-chromen-4-yl]acetyl-SDKP-OH, or coumarin-SDKP-OH, which could be an alternative to the radiolabeled analogue used in that study, allowing an easier and more rapid determination of enzyme activity. We report here the synthesis and the determination of the kinetics constants of this fluorescent derivative compared with those of [3H]AcSDKP-OH with human plasma ACE (133 and 125 microM, respectively), which are in the same range as those of the physiological substrate angiotensin I. Furthermore, the hydrolysis of the fluorescent substrate shows the same sensitivity toward chloride concentration as the natural substrate, demonstrating its specificity for N-domain hydrolysis. This fluorescent derivative was used to develop a sensitive assay for the determination of ACE activity in human plasma.

[1]  P. Deddish,et al.  Single-domain angiotensin I converting enzyme (kininase II): characterization and properties. , 1996, The Journal of pharmacology and experimental therapeutics.

[2]  J. Ménard,et al.  Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.

[3]  P. Corvol,et al.  The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme (*) , 1995, The Journal of Biological Chemistry.

[4]  H. Gavras,et al.  Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart. , 1994, Hypertension.

[5]  J. Wdzieczak‐Bakala,et al.  Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. , 1993, The Biochemical journal.

[6]  Lei Wei,et al.  Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides. , 1993, The Journal of biological chemistry.

[7]  Lei Wei,et al.  The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. , 1991, The Journal of biological chemistry.

[8]  M. Lenfant,et al.  Radiosynthesis of highly labelled [3H]Ac-Ser-Asp-Lys-Pro: A natural regulator of hematopoietic system , 1991 .

[9]  B. Bénéteau-Burnat,et al.  Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. , 1991, Critical reviews in clinical laboratory sciences.

[10]  M. Lenfant,et al.  Synthesis and activity of NAcSerAspLysPro analogues on cellular interactions between T-cell and erythrocytes in rosette formation. , 1990, Journal of medicinal chemistry.

[11]  E. Guittet,et al.  Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P Corvol,et al.  Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Vallee,et al.  Metal-coordinating substrate analogs as inhibitors of metalloenzymes. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D W Cushman,et al.  Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. , 1971, Biochemical pharmacology.

[15]  E. G. Erdös,et al.  A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. , 1970, Biochimica et biophysica acta.

[16]  L. Skeggs,et al.  THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME , 1956, The Journal of experimental medicine.